Dolby Laboratories Résultats passés
Passé contrôle des critères 1/6
Les bénéfices de Dolby Laboratories ont diminué à un taux annuel moyen de -1.4%, tandis que le secteur Software a vu ses bénéfices augmenter de en à 22.4% par an. Les revenus ont augmenté de en à un taux moyen de 1.6% par an. Le rendement des capitaux propres de Dolby Laboratories est 9.3% et ses marges nettes sont de 17.9%.
Informations clés
-1.45%
Taux de croissance des bénéfices
0.10%
Taux de croissance du BPA
| Software Croissance de l'industrie | 17.33% |
| Taux de croissance des recettes | 1.64% |
| Rendement des fonds propres | 9.34% |
| Marge nette | 17.85% |
| Dernière mise à jour des bénéfices | 27 Mar 2026 |
Mises à jour récentes des performances passées
Recent updates
Mise à jour du récit • May 17
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).Seeking Alpha • May 03
Dolby: I Don't Mind Waiting In 2026
Summary Dolby Labs is rated a 'BUY' with a conservative $80/share price target, reflecting 17–25% annualized upside potential through 2028. DLB trades at a rare sub-15x P/E, supported by robust patent-driven recurring revenue, high margins, and a net cash balance exceeding $500M. Despite cyclical end-market exposure and recent earnings volatility, DLB's technology leadership and dominant licensing position underpin long-term revenue security. A dividend yield of 2.5%, ongoing buybacks at attractive valuations, and minimal inflation sensitivity further strengthen the investment case. Read the full article on Seeking AlphaMise à jour du récit • May 01
DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains
Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
Mise à jour du récit • Apr 17
DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside
Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.Mise à jour du récit • Apr 03
DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook
Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).Mise à jour du récit • Mar 19
DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook
Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.
Mise à jour du récit • Mar 05
DLB: Media Partnerships And Buybacks Will Support Measured Future Returns
Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.Mise à jour du récit • Feb 19
DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns
Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.Mise à jour du récit • Feb 04
DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions
Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.Article d’analyse • Feb 02
Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...Mise à jour du récit • Jan 21
DLB: Technology Adoption And Solid Execution Will Support Future Share Gains
Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.Mise à jour du récit • Jan 06
DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption
Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.Article d’analyse • Jan 05
Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?
Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...Mise à jour du récit • Dec 21
DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption
Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.Mise à jour du récit • Dec 07
DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds
Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.Mise à jour du récit • Nov 23
DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds
Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.Article d’analyse • Nov 11
The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...Article d’analyse • Sep 27
Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking
When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...Mise à jour du récit • Sep 06
Expanding Auto And Device Ecosystems Will Define Immersive Entertainment
Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.Article d’analyse • Jul 28
What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
While Dolby Laboratories, Inc. ( NYSE:DLB ) might not have the largest market cap around , it had a relatively subdued...Article d’analyse • May 27
Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 33% Below Their Intrinsic Value Estimate
Key Insights Dolby Laboratories' estimated fair value is US$112 based on 2 Stage Free Cash Flow to Equity Dolby...Seeking Alpha • Feb 07
Dolby Laboratories Remains Fully Valued On Slow Growth
Summary Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely. Despite moderate growth expectations and a full stock price valuation, I maintain a Neutral rating on DLB stock due to limited upside potential. Read the full article on Seeking AlphaVentilation des recettes et des dépenses
Ventilation des recettes et des dépenses
Comment Dolby Laboratories gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 27 Mar 26 | 1,365 | 244 | 657 | 266 |
| 26 Dec 25 | 1,339 | 241 | 645 | 264 |
| 26 Sep 25 | 1,349 | 255 | 647 | 262 |
| 27 Jun 25 | 1,347 | 264 | 640 | 263 |
| 28 Mar 25 | 1,320 | 257 | 628 | 262 |
| 27 Dec 24 | 1,315 | 263 | 625 | 263 |
| 27 Sep 24 | 1,274 | 262 | 605 | 264 |
| 28 Jun 24 | 1,259 | 212 | 605 | 265 |
| 29 Mar 24 | 1,269 | 190 | 614 | 269 |
| 29 Dec 23 | 1,280 | 188 | 615 | 274 |
| 29 Sep 23 | 1,300 | 201 | 613 | 272 |
| 30 Jun 23 | 1,287 | 219 | 603 | 263 |
| 31 Mar 23 | 1,279 | 242 | 591 | 257 |
| 30 Dec 22 | 1,237 | 183 | 617 | 257 |
| 30 Sep 22 | 1,254 | 184 | 634 | 261 |
| 01 Jul 22 | 1,261 | 201 | 639 | 261 |
| 01 Apr 22 | 1,258 | 216 | 632 | 260 |
| 31 Dec 21 | 1,243 | 255 | 587 | 259 |
| 24 Sep 21 | 1,281 | 310 | 557 | 254 |
| 25 Jun 21 | 1,267 | 293 | 541 | 253 |
| 26 Mar 21 | 1,228 | 306 | 526 | 251 |
| 25 Dec 20 | 1,260 | 318 | 538 | 245 |
| 25 Sep 20 | 1,162 | 231 | 556 | 239 |
| 26 Jun 20 | 1,189 | 248 | 554 | 238 |
| 27 Mar 20 | 1,245 | 221 | 570 | 238 |
| 27 Dec 19 | 1,231 | 206 | 560 | 237 |
| 27 Sep 19 | 1,242 | 255 | 549 | 238 |
| 28 Jun 19 | 1,183 | 238 | 550 | 238 |
| 29 Mar 19 | 1,096 | 201 | 541 | 238 |
| 28 Dec 18 | 1,057 | 193 | 525 | 239 |
| 28 Sep 18 | 1,055 | 42 | 507 | 237 |
| 29 Jun 18 | 1,056 | 37 | 490 | 234 |
| 30 Mar 18 | 1,147 | 110 | 480 | 233 |
| 29 Dec 17 | 1,115 | 95 | 474 | 232 |
| 29 Sep 17 | 1,080 | 206 | 468 | 233 |
| 30 Jun 17 | 1,072 | 204 | 464 | 235 |
| 31 Mar 17 | 1,044 | 192 | 463 | 230 |
| 30 Dec 16 | 1,051 | 208 | 458 | 224 |
| 30 Sep 16 | 1,026 | 186 | 464 | 220 |
| 01 Jul 16 | 1,025 | 208 | 470 | 211 |
| 01 Apr 16 | 980 | 180 | 470 | 202 |
| 01 Jan 16 | 977 | 171 | 467 | 206 |
| 25 Sep 15 | 971 | 181 | 461 | 201 |
| 26 Jun 15 | 965 | 181 | 449 | 198 |
Des revenus de qualité: DLB a des bénéfices de haute qualité.
Augmentation de la marge bénéficiaire: Les marges bénéficiaires nettes actuelles de DLB sont inférieures à celles de l'année dernière DLB. (17.9%) sont inférieures à celles de l'année dernière (19.4%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: Les bénéfices de DLB ont diminué de 1.4% par an au cours des 5 dernières années.
Accélération de la croissance: DLB a connu une croissance négative de ses bénéfices au cours de l'année écoulée, elle ne peut donc pas être comparée à sa moyenne sur 5 ans.
Bénéfices par rapport au secteur d'activité: DLB a enregistré une croissance négative de ses bénéfices ( -5.1% ) au cours de l'année écoulée, ce qui rend difficile la comparaison avec la moyenne du secteur Software ( 11.2% ).
Rendement des fonds propres
ROE élevé: Le retour sur capitaux propres de DLB ( 9.3% ) est considéré comme faible.
Rendement des actifs
Rendement des capitaux employés
Découvrir des entreprises performantes dans le passé
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/18 20:44 |
| Cours de l'action en fin de journée | 2026/05/15 00:00 |
| Les revenus | 2026/03/27 |
| Revenus annuels | 2025/09/26 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Dolby Laboratories, Inc. est couverte par 13 analystes. 4 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Vikram Kesavabhotla | Baird |
| Patrick Sholl | Barrington Research Associates, Inc. |
| Eric Wold | B. Riley Securities, Inc. |